Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management

使用综合戒烟和情绪管理进行急性冠脉综合征的二级预防

基本信息

  • 批准号:
    9284290
  • 负责人:
  • 金额:
    $ 47.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-18 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Approximately 400,000 smokers survive an Acute Coronary Syndrome (ACS; unstable angina, ST and non-ST elevation myocardial infarction) each year in the US. The occurrence of ACS can be conceptualized as a “teachable moment,” whereby patients may be more receptive to smoking cessation messages. Continued smoking following ACS is an independent predictor of mortality. Depressed mood post-ACS is also predictive of mortality, and smokers with depressed mood are less likely to abstain from smoking following an ACS hospitalization. Thus, a single, integrated treatment that targets both depressed mood and smoking could be highly effective in reducing post-ACS mortality. Behavioral Activation may be an ideal counseling treatment for this population because it is easy to train, can be delivered by Bachelor's degree level practitioners, and has recently shown promise for enhancing cessation outcomes in smokers with depression. Through extensive pilot work we systematically developed a counseling intervention that integrates gold standard smoking cessation counseling with Behavioral Activation based mood management for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). The overall aim of the current study is to conduct a fully powered efficacy trial enrolling 324 smokers with ACS and randomizing them to 12 weeks of BAT-CS or control (including full attention match). Both groups will be offered the nicotine patch if medically cleared. Follow-up assessments will be conducted at end-of-treatment and 6, 9, and 12 months after hospital discharge. We will track the occurrence of major adverse cardiac events and all-cause mortality for 18-36 months post-discharge. The primary outcomes will be depressed mood and biochemically validated 7-day point prevalence abstinence. The specific aims of the study are: Aim I: Test the efficacy of BAT-CS vs. control on depressed mood and smoking cessation. Aim II: Test the efficacy of BAT-CS vs. control on cardiac health. Aim III: Explore hypothesized mediators of treatment effects. Aim IV: Explore the temporal interaction of smoking and multiple aspects of mood over 1 year post-ACS. The long-term goal of this line of research is to improve long-term survival rates following ACS.
项目总结/摘要 大约40万吸烟者在急性冠状动脉综合征(ACS;不稳定型心绞痛,ST和ST段抬高)中存活。 非ST段抬高型心肌梗死)。ACS的发生可以被概念化为 一个“教育的时刻,”借此病人可能更容易接受戒烟的信息。继续 ACS后吸烟是死亡率的独立预测因子。ACS后抑郁情绪也是预测 的死亡率,和吸烟者抑郁情绪不太可能戒烟后ACS 住院因此,一种针对抑郁情绪和吸烟的单一综合治疗方法可能是可行的。 在降低ACS后死亡率方面非常有效。行为激活可能是一种理想的咨询治疗, 这一人口,因为它很容易培训,可以由学士学位水平的从业人员提供,并已 最近显示出提高抑郁症吸烟者戒烟效果的希望。通过广泛 试点工作我们系统地开发了一种咨询干预, 对ACS后吸烟者进行基于行为激活的情绪管理的戒烟咨询;行为 心脏吸烟者的激活治疗(BAT-CS)。本研究的总体目标是全面开展 有把握度的疗效试验,入组324例ACS吸烟者,并将其随机分配至12周BAT-CS或 控制(包括完全注意力匹配)。如果医学许可,两组都将提供尼古丁贴片。 将在治疗结束时和住院后6、9和12个月进行随访评估 放电我们将跟踪18-36年主要不良心脏事件的发生率和全因死亡率 出院后数月。主要结果将是抑郁情绪和生化验证的7天 点流行禁欲。本研究的具体目的是:目的I:检测BAT-CS与对照组相比的疗效 抑郁情绪和戒烟的效果目的II:测试BAT-CS与对照相比对心脏健康的有效性。 目的III:探索治疗效果的假设介质。目的四:探索时间的相互作用, 吸烟和多方面的情绪超过1年后ACS。这项研究的长期目标是 提高ACS后的长期生存率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew M Busch其他文献

Homelessness and Type 2 Diabetes: A Qualitative Study of Facilitators and Barriers to Self-Management and Medication Adherence
  • DOI:
    10.1007/s11606-024-09030-z
  • 发表时间:
    2024-09-23
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Sarah Turcotte Manser;Preethiya Sekar;Zobeida Bonilla;Becky Ford;Nathan Shippee;Andrew M Busch;Lillian Gelberg;Elizabeth A Rogers;Latasha Jennings-Dedina;Victor M Montori;Katherine Diaz Vickery
  • 通讯作者:
    Katherine Diaz Vickery

Andrew M Busch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew M Busch', 18)}}的其他基金

Multisite feasibility of BA-HD: An integrated depression and behavioral risk factor reduction coaching program following acute coronary syndrome
BA-HD 的多地点可行性:急性冠脉综合征后的综合抑郁症和行为危险因素减少辅导计划
  • 批准号:
    10680636
  • 财政年份:
    2023
  • 资助金额:
    $ 47.5万
  • 项目类别:
Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management
使用综合戒烟和情绪管理进行急性冠脉综合征的二级预防
  • 批准号:
    10392843
  • 财政年份:
    2017
  • 资助金额:
    $ 47.5万
  • 项目类别:
Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management
使用综合戒烟和情绪管理进行急性冠脉综合征的二级预防
  • 批准号:
    9994997
  • 财政年份:
    2017
  • 资助金额:
    $ 47.5万
  • 项目类别:
Exploring the Effects of Strength Training on Depressive Symptoms and Cardiovascular Risk in Black Men
探索力量训练对黑人抑郁症状和心血管风险的影响
  • 批准号:
    9357672
  • 财政年份:
    2016
  • 资助金额:
    $ 47.5万
  • 项目类别:
Integrated Smoking Cessation and Mood Management for ACS Patients
ACS 患者的综合戒烟和情绪管理
  • 批准号:
    9324458
  • 财政年份:
    2016
  • 资助金额:
    $ 47.5万
  • 项目类别:
Exploring the Effects of Strength Training on Depressive Symptoms and Cardiovascular Risk in Black Men
探索力量训练对黑人抑郁症状和心血管风险的影响
  • 批准号:
    9182593
  • 财政年份:
    2016
  • 资助金额:
    $ 47.5万
  • 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
  • 批准号:
    8258254
  • 财政年份:
    2011
  • 资助金额:
    $ 47.5万
  • 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
  • 批准号:
    8089834
  • 财政年份:
    2011
  • 资助金额:
    $ 47.5万
  • 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
  • 批准号:
    8449738
  • 财政年份:
    2011
  • 资助金额:
    $ 47.5万
  • 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
  • 批准号:
    8650313
  • 财政年份:
    2011
  • 资助金额:
    $ 47.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了